Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Celcuity Inc. Common Stock
Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date: September 20, 2017
Sector: Healthcare
Industry: Medical Diagnostics and Research
Market Cap: $4.89B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.49 | 2.97%
Avg Daily Range (30 D): $2.31 | 2.72%
Avg Daily Range (90 D): $2.03 | 3.25%
Institutional Daily Volume
Avg Daily Volume: .13M
Avg Daily Volume (30 D): .75M
Avg Daily Volume (90 D): .99M
Trade Size
Avg Trade Size (Sh.): 65
Avg Trade Size (Sh.) (30 D): 48
Avg Trade Size (Sh.) (90 D): 57
Institutional Trades
Total Inst.Trades: 727
Avg Inst. Trade: $2.83M
Avg Inst. Trade (30 D): $4.8M
Avg Inst. Trade (90 D): $3.39M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.11M
Avg Closing Trade (30 D): $6.9M
Avg Closing Trade (90 D): $5.67M
Avg Closing Volume: 122.6K
   
News
Dec 4, 2025 @ 9:47 AM
3 Stocks You’ll Wish You Bought Before 2026...
Source: Chris Markoch
Nov 27, 2025 @ 10:22 PM
This Fund Bought $38 Million of Celcuity as Stock ...
Source: Jonathan Ponciano
Oct 18, 2025 @ 8:30 AM
Detailed Results from PIK3CA Wild-Type Cohort o...
Source: Celcuity Inc.
Oct 18, 2025 @ 8:30 AM
Celcuity Presents Updated Data at the 2025 ESMO Co...
Source: Celcuity Inc.
Oct 18, 2025 @ 8:30 AM
Celcuity Provides Update on Status of the PIK3CA M...
Source: Brian Sullivan
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-3.68 $-.92 $-1.04
Diluted EPS $-3.68 $-.92 $-1.04
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -162.72M $ -43.8M $ -45.27M
Operating Income / Loss $ -159.42M $ -42.85M $ -44.01M
Cost of Revenue $ $ $
Net Cash Flow $ 61.65M $ 27.9M $ 29.88M
PE Ratio